Clinical Trials Directory

Trials / Completed

CompletedNCT00603681

Comparison of PEG Solutions With and Without Electrolytes in the Treatment of Constipation

Non-Inferiority Study; Comparison of Polyethylene Glycol Solution With and Without Electrolytes for Treatment of Chronic Constipation in Elderly Institutionalised Patients: a Double-Blind, Randomised, Parallel-Group, Multicentre Study

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
67 (actual)
Sponsor
Orion Corporation, Orion Pharma · Industry
Sex
All
Age
65 Years
Healthy volunteers
Not accepted

Summary

The aim of the study is to show that new polyethylene glycol (PEG) solution without electrolytes is as effective in the treatment of constipation as PEG solution with electrolytes in the elderly institutionalized people. Also, the tolerability and the safety of the study drug will be examined.

Detailed description

Constipation is a major problem in elderly institutionalised patients. Non-pharmacological treatments are proposed as primary management of constipation, but institutionalised patients are not likely to be able to increase either the intake of dietary fibre or fluid and their physical activity is low. The latest agent widely used for the treatment of constipation is polyethylene glycol (PEG). PEG is classified into the group of osmotic laxatives. It is minimally absorbed from the gastrointestinal tract and not metabolised by colonic bacteria. Most of the PEG products at the market contain electrolytes and have a salty and unpleasant taste which may affect the compliance of using them. A PEG solution without electrolytes has been developed and used for some years in various countries. Now we will compare the efficacy and safety of PEG solutions with or without electrolytes and their acceptability in the use for constipation in institutionalised patients.

Conditions

Interventions

TypeNameDescription
DRUGPolyethylene glycol 4000powder for oral solution 12 g of PEG once a day, twice a day or once every other day for 4 weeks
DRUGPolyethylene glycol 4000 with electrolytesgranules for oral solution 12 g of PEG once a day, twice a day or once every other day for 4 weeks

Timeline

Start date
2008-01-01
Primary completion
2008-07-01
Completion
2008-07-01
First posted
2008-01-29
Last updated
2008-10-07

Locations

10 sites across 1 country: Finland

Source: ClinicalTrials.gov record NCT00603681. Inclusion in this directory is not an endorsement.